Thousands observed: is this sedative safe for routine scopes?
NCT ID NCT05254366
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study observed over 2,000 patients in China who received remimazolam, a short-acting sedative, during painless gastroscopy or colonoscopy. The goal was to collect real-world safety information, including side effects and serious adverse events. No new treatment was given; researchers simply watched and recorded what happened.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Remimazolam (a short-acting sedative)
What this could lead to
If successful, this study could confirm that remimazolam is safe for routine use during gastroscopy and colonoscopy in Chinese patients.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove effectiveness. Results may not apply to other populations or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROSCOPIC AND COLONOSCOPIC SEDATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430021, China